PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A groundbreaking discovery of a common master switch to cure Alzheimer’s, Parkinson’s, and other brain-related diseases

Davis Joseph's breakthrough could save millions of lives

2025-05-19
(Press-News.org) The 21st edition of Sustainability Through Science and Technology Summit 2025 (SIPS 2025), dedicated to Prof. Aaron Ciechanover, Nobel Laureate in Chemistry, to be held in Cebu, Philippines, from 17-20 November 2025, has confirmed the participation of Davis Joseph as an invited summit plenary lecturer for his recent ground-breaking discovery of the common master switch for numerous brain-related diseases.

Davis Joseph discovered something that could not be found in the entire scientific history of Alzheimer’s and Parkinson’s research: a common master switch that can potentially cure both these and other brain-related diseases with a single method, despite the unique characteristics of each disease. This was achieved by developing a unified theory, which establishes that the occurrence and progression of these neurodegenerative diseases can be controlled mainly by regulating the rates of axon-based 4E-BP2 protein deamidation, a chemical reaction that disrupts protein function, whose fundamental mechanism in the brain was recently discovered by Davis Joseph. Since the common characteristic of these diseases in aging patients is an excessive 4E-BP2 protein deamidation that causes protein overproduction and malfunction, lowering the common master switch to bring the deamidation rates to normal values, depending on the patients' characteristics, can cure these brain-related diseases.

This breakthrough is significant because Parkinson’s disease, first described in 1817, Alzheimer’s disease, first described in 1906, and other neurodegenerative diseases have been studied separately in biochemistry and therapeutic drug development, and no causal link has ever been established between them. Davis Joseph discovered this link and made the dividing wall between these brain-related diseases disappear, making it possible to treat them by regulating a shared master switch.

Additionally, this breakthrough is crucial since it bridges for the first time four different research fields: the biochemical processes of deamidation, translational control, oxidative stress, and neurodegeneration through axon-based 4E-BP2 protein deamidation that serves as a common denominator for all of them.

Furthermore, this discovery is an example of sustainable medicine as per FLOGEN Sustainability Framework because it fulfills the three criteria of sustainability: (1) Social Development since it improves the quality of human life (2) Economic Development, since it decreases the cost of medicine applicable to numerous diseases and (3) Environment Protection since it decreases the amount of resources that is needed to produce medicine.

Based on this newly developed Unified Theory and his critical review of the scientific literature, he also designed for the first time three biochemical flowsheets of (1) deamidation in living organisms, (2) protein synthesis initiation and translational control, and (3) 4E-BP2 deamidation as a control system of the four biochemical processes.

The discovery was published on April 27th, 2025, in the prestigious International Journal of Molecular Sciences (IJMS), a Q1 journal. The full paper given here https://www.mdpi.com/1422-0067/26/9/4143 has been accessed more than 1700 times in less than 21 days, a world record for a single-author scientific publication. The discovery and this publication have been covered by more than 500 media organizations around the word (https://www.flogen.org/?p=98#toop). It was also presented as a plenary lecture at the Congress of Modern Sustainable Medicine in Asuncion, Paraguay, on 30th April 2025.

This is Davis Joseph's second discovery in the last five months. The first discovery, known as Davis Joseph’s principle, was the fundamental neurobiological mechanism of 4E-BP2 protein deamidation, which determined that axons, a cable-like structure of brain cells, are the key factor of deamidation in the brain. This first discovery, described as Nobel Prize worthy by Dr. Harvey Alter and Dr. Gregg Semenza, 2020 and 2019 Nobel Laureates in Physiology and Medicine, respectively, was published on November 15, 2024, also in IJMS. The full paper (https://www.mdpi.com/1422-0067/25/22/12268) has been accessed more than 8000 times in less than 6 months, another world record for a single-author scientific publication, and has been covered by more than 500 media outlets, including the Associated Press: https://apnews.com/press-release/ein-presswire-newsmatics/medical-research-b14b0c18105eac4f46e9e14b74f72cbc. For this discovery, Davis Joseph was awarded Semenza International Cell Engineering Award at the FLOGEN Stars Outreach/2024 Sustainability through Science and Technology Summit (SIPS 2024) held in Crete, Greece in October 2024. (https://www.flogen.org/?p=195&bio=2024_Davis_Joseph)

”Alzheimer’s and Parkinson’s diseases are two awful diseases, and Davis's work to try to combat them is extraordinary. I am proud to be his representative in the House of Commons”, says Anthony Housefather, Member of Parliament, Canada

Photos, full videos of the presentation and an interview can be viewed here: https://www.flogen.org/?p=33&an=2025&m=4

About:
Davis Joseph is a researcher at the Faculty of Medicine, McGill University and Biochemistry Research Director at FLOGEN Technologies Inc. Davis has received 18 honors, awards, and distinctions for his academic performance in Mathematics (twice), Natural and Social Sciences (twice), French, English (twice), awards for his overall academic results and his service to his community from various Canadian institutions including the Collège Notre-Dame, Collège Jean-de-Brébeuf and the Montreal Geriatric Institution. He is recipient of 2024 Semenza International Cell Engineering Award named after Nobel Laureate in chemistry, Prof. Gregg Semenza.

FLOGEN Technologies (www.flogen.com) is a High-Tech applied research institute dedicated to developing new sustainable technologies and transforming existing ones into sustainable ones in four different fields: Biochemistry, Chemistry, Metals Extraction, and Environment, based on the FLOGEN Sustainability Framework.

FLOGEN Stars Outreach (www.flogen.org), is a not-for-profit corporation dedicated to achieving sustainability through science and technology, raising the profile of science and engineering in society and properly honoring scientists and engineers.

SIPS - Sustainability through Science and Technology Summit (https://www.flogen.org/sips2025/) is a science-focused and industrial engineering-oriented multidisciplinary conference held every year around the world with an average participation of five hundred authors from academia, industry, government, and the entrepreneurship world representing on average 80 countries. The summit is dedicated to achieving sustainability through science and technology and hosts numerous Nobel Laureates regularly.

FLOGEN sustainability Framework (https://www.flogen.org/?p=206#toop ) is an innovative concept that establishes 3 criteria to be achieved simultaneously to be Sustainable i.e. Environmental Protection, Social Development and Economic Growth sustained by three equally important pillars/actors i.e. Science and Technology, Governance and management and Education and Civil Society. In September 2024, this framework became a constitutional law in the city of Nova Friburgo, Rio de Janeiro, Brazil, a first in the world in which a scientific concept is transformed into law.

END


ELSE PRESS RELEASES FROM THIS DATE:

Novel data streaming software chases light speed from accelerator to supercomputer

2025-05-19
Analyzing massive datasets from nuclear physics experiments can take hours or days to process, but researchers are working to radically reduce that time to mere seconds using special software being developed at the Department of Energy’s Lawrence Berkeley and Oak Ridge national laboratories.   DELERIA — short for Distributed Event-Level Experiment Readout and Integrated Analysis — is a novel software platform designed specifically to support the GRETA spectrometer, a cutting-edge instrument for nuclear physics experiments. The Gamma Ray Energy Tracking Array, or GRETA, ...

UK child sexual abuse survivors lack support - report

2025-05-19
Over 640 victims and survivors of child sexual abuse and exploitation in the UK have shared their stories in a global effort to raise awareness about the realities of sexual violence against children, the challenges of disclosure and recovery, and its enduring impact on their lives. Their voices are amplified through a powerful report published by the Finnish child-rights organisation Protect Children in collaboration with the International Policing and Public Protection Research Institute (IPPPRI), part of Anglia Ruskin University in England. At IPPPRI25 - the research institute’s annual conference dedicated to tackling online harms - on ...

Rice’s Mikos elected to the European Academy of Sciences

2025-05-19
HOUSTON – (May 19, 2025) – Antonios Mikos, the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University, has been elected to the European Academy of Sciences (EURASC), an international body that recognizes excellence in scientific research and technological innovation. A global leader in biomaterials and tissue engineering, Mikos is widely known for his groundbreaking work in regenerative medicine, controlled drug delivery, gene therapy and disease modeling. ...

Hari Kalva, Ph.D., inducted into the Florida Inventors Hall of Fame

2025-05-19
Hari Kalva, Ph.D., a pioneering innovator in video technology and professor and chair of the Department of Electrical Engineering and Computer Science in Florida Atlantic University’s College of Engineering and Computer Science, has been named a 2025 inductee of the Florida Inventors Hall of Fame. Kalva is one of 10 inventors selected for the 2025 class, which spans disciplines from nanotech and regenerative medicine to clean energy and next-gen video systems. Their work has defined new frontiers, advanced scientific breakthroughs, and embodied the spirit of innovation that drives Florida’s expanding landscape ...

Machine learning model helps identify patients at risk of postpartum depression

2025-05-19
Postpartum depression (PPD) affects up to 15 percent of individuals after childbirth. Early identification of patients at risk of PPD could improve proactive mental health support. Mass General Brigham researchers developed a machine learning model that can evaluate patients’ PPD risk using readily accessible clinical and demographic factors. Findings demonstrating the model’s promising predictive capabilities are published in the American Journal of Psychiatry. “Postpartum depression is one of the biggest challenges that some parents may experience in the period after childbirth – a time ...

The US has a new most powerful laser

2025-05-19
    Photos in the laser facility  //  Animated fly-through of the ZEUS laser system   The ZEUS laser facility at the University of Michigan has roughly doubled the peak power of any other laser in the U.S. with its first official experiment at 2 petawatts (2 quadrillion watts).    At more than 100 times the global electricity power output, this huge power lasts only for the brief duration of its laser pulse—just 25 quintillionths of a second long.   "This milestone marks the beginning of experiments that move into unexplored ...

Team creates light-activated therapy to target hard-to-treat cancer

2025-05-19
University of Texas at Dallas bioengineers, in collaboration with UT Southwestern Medical Center researchers, are developing an enhanced light-activated immunotherapy approach that could one day treat patients with stomach cancer that has spread throughout the abdomen. The approach uses lab-designed molecules and far-red or near-infrared light to “prime” the immune system to help it attack stubborn cancer cells, said Dr. Girgis Obaid, assistant professor of bioengineering in the Erik Jonsson School of Engineering and Computer Science. The lab-designed molecules, or betabodies, target only tumors, leaving healthy tissue unaffected to reduce side effects. “When ...

Tiny microlaser sensors offer supercharged biosensing

2025-05-19
WASHINGTON — Researchers have developed a 3D micro-printed sensor for highly sensitive on-chip biosensing. The sensor, which is based on a polymer whispering-gallery-mode microlaser, opens new opportunities for developing high-performance, cost-effective lab-on-a-chip devices for early disease diagnosis. “In the future, these whispering-gallery-mode microlaser sensors could be integrated into a microfluidic chip to enable a new generation of lab-on-chip devices for ultrasensitive quantitative detection of multiple biomarkers,” ...

Having a team therapist reduces burnout in critical care nurses

2025-05-19
EMBARGOED UNTIL: May 19, 2025, 9:15 a.m. PT Having a Team Therapist Reduces Burnout in Critical Care Nurses Session:  B17 — The Power of Team Science: Interdisciplinary Approaches to Pulmonary and Critical Care One of Us. The Value of Having a Team Therapist to Support Nursing Staff in Critical Care Areas Date and Time: May 19, 2025, 9:15 a.m. PT Location:  Room 3014/3016/3018 (West Building, Level 3), Moscone Center ATS 2025, San Francisco – Adding a team therapist to support nurses in critical care areas can reduce burnout ...

Ciliary dysfunction linked to bronchopulmonary dysplasia severity

2025-05-19
Session: B18 — Best in Pediatrics Analyzing Respiratory Cilia Dynamics in Relation to Bronchopulmonary Dysplasia Severity Date and Time: May 19, 2025, 9:15 a.m. PT Location: Room 2018/2020 (West Building, Level 2), Moscone Center   ATS 2025, San Francisco – Premature infants are at risk of bronchopulmonary dysplasia, or BPD, a type of lung injury associated with increased mortality. Now a new study published at the ATS 2025 International Conference shows that ciliary dynamics may play a role in the pathophysiology of this disease. Researchers found that infants with more severe BPD showed signs of ciliary dysfunction that were not present ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

[Press-News.org] A groundbreaking discovery of a common master switch to cure Alzheimer’s, Parkinson’s, and other brain-related diseases
Davis Joseph's breakthrough could save millions of lives